Ontology highlight
ABSTRACT: Background
Whole exome sequencing (WES) allows for an unbiased search of the genetic cause of a disease. Employing it as a first-tier genetic testing can be favored due to the associated lower incremental cost per diagnosis compared to when using it later in the diagnostic pathway. However, there are technical limitations of WES that can lead to inaccurate negative variant callings. Our study presents these limitations through a re-evaluation of negative WES results using subsequent tests primarily driven by fundoscopic findings. These tests included targeted gene testing, inherited retinal gene panels, whole genome sequencing (WGS), and array comparative genomic hybridization.Results
Subsequent genetic testing guided by fundoscopy findings identified the following variant
SUBMITTER: Cho A
PROVIDER: S-EPMC6993391 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature